Page 109 - 《中国药房》2024年5期
P. 109
参考文献 [ 9 ] 李丰杉,余勤 . 儿童用药研发及儿科临床试验的国际发
[ 1 ] LAM S H F,HOMME J,AVARELLO J,et al. Use of anti‐ 展和国内现状[J]. 中国新药杂志,2020,29(17):1933-
tussive medications in acute cough in young children[J]. J 1938.
Am Coll Emerg Physicians Open,2021,2(3):e12467. LI F S,YU Q. International development and domestic
[ 2 ] 陈星,罗征秀,沈照波,等 . 儿童祛痰止咳治疗专家共识 situation of pediatric medication development and clinical
[J].中国实用儿科杂志,2022,37(8):567-574. trials[J]. Chin J N Drugs,2020,29(17):1933-1938.
CHEN X,LUO Z X,SHEN Z B,et al. Expert consensus [10] WU W J,TANG Z J,CHEN J Y,et al. Pediatric drug de‐
on expectorant and relieving cough in children[J]. Chin J velopment in China:reforms and challenges[J]. Pharmacol
Pract Pediatr,2022,37(8):567-574. Res,2019,148:104412.
[ 3 ] 梁盛华,许志威. 镇咳、祛痰药物研究进展[J]. 中国药房, [11] 池里群,于景娴 . 360 份儿童用药药品说明书中关于用
2015,26(25):3578-3580. 药剂量的调查分析[J]. 中国临床药学杂志,2019,28(2):
138-140.
LIANG S H,XU Z W. Research progress of antitussive
CHI L Q,YU J X. Investigation and analysis on dosage of
and expectorant drugs[J]. China Pharm,2015,26(25):
drugs in 360 drug instructions for children[J]. Chin J Clin
3578-3580.
Pharm,2019,28(2):138-140.
[ 4 ] 马骏威,任连杰. 药品说明书中儿童用法用量药学信息
[12] 国家食品药品管理总局.总局关于发布儿科人群药物临床
的撰写与思考[J]. 中国医药工业杂志,2022,53(11):
试验技术指导原则的通告[EB/OL].[2023-04-14]. https://
1583-1587.
www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20160307164401912.
MA J W,REN L J. Consideration of pharmaceutical infor‐
html.
mation writing in posology and method of administration
National Medical Products Administration. Notice of the
of pediatric information of labeling[J]. Chin J Pharm,
general administration of the people’s republic of China
2022,53(11):1583-1587.
on issuing technical guiding principles for clinical trials
[ 5 ] 宋菲,冯逸佳,张研,等. 我国医保儿童专用药发展历程
of drugs in pediatric population[EB/OL]. [2023-04-14].
与前景分析[J]. 中国医疗保险,2022(11):39-44.
https://www. nmpa. gov. cn/xxgk/ggtg/qtggtg/2016030716-
SONG F,FENG Y J,ZHANG Y,et al. Analysis on the de‐
4401912.html.
velopment and prospect of children’s medicine in national
[13] 国家食品药品管理总局 . 关于公开征求《已上市药品说
catalog of drugs covered by basic medical insurance[J].
明书增补儿童用药信息工作程序》及《药审中心关于已
China Health Insur,2022(11):39-44.
上市药品说明书增补儿童用药信息的工作流程》意见的
[ 6 ] 闫聪聪,王晓玲,张胜男,等 . 国内 8 家儿童医院常用药
通知[EB/OL].[2023-04-14].https://www.cde.org.cn/main/
品说明书中儿童用药信息的调查分析[J]. 中国药事,
news/viewInfoCommon/e54a666a01efaf04fle55a7ddf728-
2021,35(1):10-15.
a06.
YAN C C,WANG X L,ZHANG S N,et al. Investigation
National Medical Products Administration. Notice on pub‐
and analysis into children medication information in pedia-
licly soliciting opinions on Working Procedures for
tric commonly-used drug instructions in 8 children’s hos‐
Supplementing Children’s Drug Use Information to
pitals[J]. Chin Pharm Aff,2021,35(1):10-15.
Listed Drug Instructions and Working Procedures for
[ 7 ] 王谦,张怡,梁宇光,等. 儿童常用药品说明书药物代谢
SuppleMenting Children’s Drug Use Information to
动力学信息标注情况分析[J]. 临床药物治疗杂志,2021, Listed Drug Instructions by Drug Testing Center[EB/OL].
19(10):76-80. [2023-04-14].https://www.cde.org.cn/main/news/view-
WANG Q,ZHANG Y,LIANG Y G,et al. Analysis on InfoCommon/e54a666a01efaf04fle55a7ddf728a06.
children’s pharmacokinetic information of labeling for [14] 王雅君,韩容,岳志华,等. 美国儿童药品上市审批情况
pediatric drug[J]. Clin Med J,2021,19(10):76-80. 分析及其对我国儿童用药保障工作的启示[J]. 中国药
[ 8 ] 马津京,张艳菊,胡利华,等. 13家医疗机构儿科常用中 房,2021,32(2):133-138.
成药说明书信息及标注情况分析[J]. 儿科药学杂志, WANG Y J,HAN R,YUE Z H,et al. Analysis of the mar‐
2021,27(11):22-26. keting approval of pediatric drugs in the United States and
MA J J,ZHANG Y J,HU L H,et al. Information and an‐ its enlightenment to pediatric drug use guarantee in China
notation in instructions of commonly used Chinese patent [J]. China Pharm,2021,32(2):133-138.
medicine in pediatrics of 13 medical institutions[J]. J Pediatr (收稿日期:2023-06-29 修回日期:2023-12-17)
Pharm,2021,27(11):22-26. (编辑:刘明伟)
中国药房 2024年第35卷第5期 China Pharmacy 2024 Vol. 35 No. 5 · 611 ·